Effects of Simvastatin on Cartilage Homeostasis in Steroid-Induced Osteonecrosis of Femoral Head by Inhibiting Glucocorticoid Receptor

Cells. 2022 Dec 7;11(24):3945. doi: 10.3390/cells11243945.

Abstract

Steroid-induced osteonecrosis of femoral head (SONFH) is one of the most common bone disorders in humans. Statin treatment is beneficial in preventing the development of SONFH through anti-inflammation effects and inhibition of the glucocorticoid receptor (GR). However, potential mechanisms of statin action remain to be determined. In this study, pulse methylprednisolone (MP) treatment was used to induce SONFH in broilers, and then MP-treated birds were administrated with simvastatin simultaneously to investigate the changes in cartilage homeostasis. Meanwhile, chondrocytes were isolated, cultured, and treated with MP, simvastatin, or GR inhibitor in vitro. The changes in serum homeostasis factors, cell viability, and expression of GR were analyzed. The results showed that the morbidity of SONFH in the MP-treated group increased significantly compared with the simvastatin-treated and control group. Furthermore, MP treatment induced apoptosis and high-level catabolism and low-level anabolism in vitro and vivo, while simvastatin significantly decreased catabolism and slightly recovered anabolism via inhibiting GR and the hypoxia-inducible factor (HIF) pathway. The GR inhibitor or its siRNA mainly affected the catabolism of cartilage homeostasis in vitro. In conclusion, the occurrence of SONFH in broilers was related to the activation of GR and HIF pathway, and imbalance of cartilage homeostasis. Simvastatin and GR inhibitor maintained cartilage homeostasis via GR and the HIF pathway.

Keywords: HIF pathway; cartilage homeostasis; glucocorticoid receptor; simvastatin; steroid-induced osteonecrosis of femoral head.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cartilage
  • Chickens
  • Femur Head / metabolism
  • Homeostasis
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors*
  • Methylprednisolone / pharmacology
  • Osteonecrosis* / metabolism
  • Receptors, Glucocorticoid / metabolism
  • Simvastatin / pharmacology

Substances

  • Receptors, Glucocorticoid
  • Simvastatin
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Methylprednisolone

Grants and funding

This work was supported by the National Natural Science Foundation of China (grant 32273080 and grant 32072936). The fund was used for experimental research, purchase of consumables, personnel employment, results analysis, and so on.